62 - Hot Topic Breakfast - The Future of Myopia Management: Perspectives from Leading Experts

Friday, February 28, 2025

8:00 AM – 10:45 AM EST

Location: Georgia World Congress Center, 411/412

CE Hours: 2

Moderator(s)

Katherine K. Weise, OD, MBA, FAAO

Hoover, AL, United States

Disclosure(s): No financial relationships to disclose

Panelist(s)

Brianna Rhue, OD, FAAO, FSLS

Tamarac, FL, United States

Disclosure(s): No relevant disclosure to display
Debbie Jones, OD

Waterloo, ON, Canada

Disclosure(s): No relevant disclosure to display
Safal Khanal, OD

AL, United States

Disclosure(s): No relevant disclosure to display

Disclosure(s):

Katherine K. Weise, OD, MBA, FAAO: No financial relationships to disclose

Brianna Rhue, OD, FAAO, FSLS: No relevant disclosure to display

Debbie Jones, OD: No relevant disclosure to display

Safal Khanal, OD: No relevant disclosure to display

Dive into the latest findings from the 2024 National Academies of Sciences, Engineering, and Medicine (NASEM) report on myopia. With 14 months of work and decades of research, this comprehensive report sheds light on the rising incidence of myopia, its pathogenesis, and treatment advancements. Leading optometrists and researchers explore practical applications of the report’s insights and discuss how to translate groundbreaking research into clinical practice. Topics include novel treatments, optical interventions, pharmacological approaches, and more.

Learning Objectives:

Upon conclusion of this activity, attendees will be able to:

Understand the key findings of the 2024 NASEM report on myopia and its implications for clinical practice
Evaluate emerging and novel myopia treatment options based on the NASEM recommendations
Evaluate existing treatment options and new directions for optical, pharmacological, and combination therapies
Explore real-world applications of new technologies including FDA-approved contact lenses as well as not-yet FDA-approved spectacle designs available outside US
Discuss the micro business aspects of myopia management and how to balance new revenue streams with access to care in private practice
Discuss the macro business aspects of myopia management and how the cost-benefit analysis holds up when evaluating lifelong ocular morbidities